Oral Antiseptics Market size was over USD 2.75 billion in 2024 and is anticipated to cross USD 5.12 billion by 2037, growing at more than 4.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of oral antiseptics is estimated at USD 2.97 billion.
As people become more aware of the significance of maintaining oral hygiene they are increasingly inclined to invest in products for oral care including antiseptics. Consequently, there has been an increase in the demand for oral antiseptics especially among individuals dealing with dental issues like gum disease and cavities. World Health Organization reports that there have been over 2 billion cases of caries in teeth globally, with an estimated average prevalence rate of 29%.
Over the counter oral antiseptics are readily accessible making them convenient for individuals to include in their oral hygiene regimen. These antiseptics are quite effective in eradicating bacteria in the mouth that may lead to cavities, gingivitis and unpleasant breath. Moreover, they come in forms, like mouthwashes and toothpastes allowing users to combine them with brushing and flossing for improved oral care.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.9% |
|
Base Year Market Size (2024) |
USD 2.75 billion |
|
Forecast Year Market Size (2037) |
USD 5.12 billion |
|
Regional Scope |
|
Chemical (Composition Chlorhexidine Gluconate, Cetylpyridinium Chloride, Herbs & Essential Oils, and Others)
The cetylpyridinium chloride segment in the oral antiseptics market is estimated to gain the largest market share of about 73% in the year 2037. The segment growth can be attributed to its diverse range of applications and effectiveness. Cetylpyridinium chloride is anticipated to exert a mechanism of action that reduces new dental plaque growth, reduces or removes existing dental plaque, diminishes the growth of pathogenic bacteria, and inhibits the production of virulence factors when added to mouthwashes, toothpaste, tablets, or mouth sprays. As per the reported study, mouthwash, and toothpastes with cetylpyridinium chloride counteract the virus that causes COVID-19 by 99 percent.
Application (Treatment, and Prevention)
The prevention segment in the oral antiseptics market is estimated to gain the significant share in the year 2037. The segment growth can be attributed to the rising adoption of oral antiseptics among youth for preventing oral infections. An antibacterial mouthwash can effectively reduce and control plaque and gingivitis. Moreover, clinical studies have shown that even without mechanical teeth cleaning, an Octenident antiseptic can temporarily lower the bacterial load in the oral cavity and prevent plaque formation
Our in-depth analysis of the global market includes the following segments:
|
Chemical |
|
|
Application |
|
|
Form |
|
|
Distribution Channel |
|
APAC Market Statistics
Oral antiseptics market in Asia Pacific, amongst the market in all the other regions, is anticipated to hold the largest with a share of about 36% by the end of 2037. The market growth in the region is also expected on account of the presence of large base of consumers for oral antiseptic products. The Asia Pacific region also offers significant opportunities for companies well positioned to meet the market's demands and provide high-quality oral antiseptics to customers. Moreover, the COVID-19 pandemic has led to an increased focus on health and wellness, and consumers have been seeking products to help them stay healthy and protect themselves against the virus. This has driven demand for oral antiseptics and oral health monitors that are marketed as being effective against viruses and bacteria. For instance, a pre-procedure mouthwash containing oxidizing agents, such as 1% hydrogen peroxide or 0.2% povidone-iodine, is advised since SARS-CoV-2 is susceptible to oxidation. This will help to lower the microbial load in saliva and the potential for SARS-CoV-2 transmission.
North American Market Forecast
North America industry is poised to dominate majority revenue share of 36% by 2037. The market’s expansion can be attributed majorly to the surging incidence of oral cancer in the region, which is increasing the demand for oral antiseptics. Furthermore, the rising e-cigarettes trend among the youth in countries such as U.S is further expected to drive the growth of the market in the region. In addition, the North America region has large supermarkets, and drug stores that distribute oral antiseptics to the consumers. Hence, all these factors are predicted to rise the market’s growth in the region.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?